Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial. (Record no. 28881195)

MARC details
000 -LEADER
fixed length control field 02397 a2200637 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518001232.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201905s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2468-1253
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/S2468-1253(18)30269-3
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Romera, Alvaro
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20190528
245 00 - TITLE STATEMENT
Title Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The lancet. Gastroenterology & hepatology
Date of publication, distribution, etc. 12 2018
300 ## - PHYSICAL DESCRIPTION
Extent 845-855 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents, Immunological
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Area Under Curve
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bevacizumab
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biosimilar Pharmaceuticals
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Camptothecin
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Colorectal Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fluorouracil
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Intention to Treat Analysis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leucovorin
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Metastasis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Organoplatinum Compounds
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Progression-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Therapeutic Equivalency
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Peredpaya, Sergiy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shparyk, Yaroslav
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bondarenko, Igor
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mendonça Bariani, Giovanni
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Abdalla, Kathia Cristina
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Roca, Enrique
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Franke, Fábio
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Melo Cruz, Felipe
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ramesh, Anita
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ostwal, Vikas
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shah, Pradeep
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rahuman, Sajeed Abdul
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Paravisini, Alexandra
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Huerga, Camino
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Del Campo García, Ana
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Millán, Susana
773 0# - HOST ITEM ENTRY
Title The lancet. Gastroenterology & hepatology
Related parts vol. 3
-- no. 12
-- p. 845-855
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/S2468-1253(18)30269-3">https://doi.org/10.1016/S2468-1253(18)30269-3</a>
Public note Available from publisher's website

No items available.